This code system http://fhir.ch/ig/ch-crl/CodeSystem/nkrs-variables defines the following codes:
Code | Display |
3.6.2 | Associated in situ tumour |
3.9.1 | ICCC-3 main group |
3.9.2 | ICCC-3 code |
3.9.3 | ICCC-3 extended code |
4.19 | COG staging |
4.20 | COG ALL staging |
4.21 | FIGO staging |
4.22 | INRGSS staging |
4.23 | IRSS staging |
4.24 | Lugano staging |
4.25 | PRETEXT staging |
4.28 | Rhabdomyosarcoma site staging |
4.30 | DSSplus |
4.31 | SIOP staging |
4.32 | St. Jude / Murphy staging |
4.33.2 | Toronto Tier II (manual) staging |
4.34 | Creasman grading system |
4.35 | Elston/Ellis grading system |
4.36 | SalzerKuntschik grading system |
4.37 | Shimada grading system |
4.38 | WHO(CNS) grading system |
4.39 | Clinical tumour size |
4.40 | Pathological tumour size |
6.1 | Residual invasive tumour |
6.2 | Residual in-situ tumour |
6.3 | Resection margin invasive tumour |
6.4 | Resection margin in-situ tumour |
8.4 | Morphology term before change of main diagnosis |
8.5 | Morphology term after Transformation |
8.6 | Topography(s) of post-diagnosis metastases |
10.3 | HIV/AIDS |
10.9 | Cerebrovascular Accident or Transient Ischemic Attack |
10.11 | Hemiplegia / Paraplegia |
10.12 | Connective Tissue Disease - Rheumatic disease |